QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL04 IMMUNOSUPPRESSANTS
QL04A IMMUNOSUPPRESSANTS
QL04AL Neonatal fragment crystallizable receptor (FcRn) inhibitors
QL04AL01 efgartigimod alfa
QL04AL02 rozanolixizumab
QL04AL03 nipocalimab
Last updated: 2026-02-12

